Richard Buchsbaum
Overview
Explore the profile of Richard Buchsbaum including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
1158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barca E, Kroopnick A, Houck A, Thakur K, Dugue R, Zolkipli-Cunningham Z, et al.
Neurology
. 2025 Feb;
102(7_supplement_1):6306.
PMID: 39977896
Objective: This analysis of Adult-Onset Leigh Syndrome (LS) patients from the North American Mitochondrial Disease Consortium (NAMDC) Registry aims to enhance clinical insights, improve diagnoses, and uncover potential modifiers. Background:...
2.
Kimhy D, Ospina L, Wall M, Alschuler D, Jarskog L, Ballon J, et al.
JMIR Ment Health
. 2025 Feb;
12:e68251.
PMID: 39951622
Background: Aerobic exercise (AE) training has been shown to enhance aerobic fitness in people with schizophrenia. Traditionally, such training has been administered in person at gyms or other communal exercise...
3.
Sparks J, Michelassi F, Thompson J, Buchsbaum R, Pires N, DeRosa J, et al.
Ther Adv Rare Dis
. 2024 Mar;
5:26330040241227452.
PMID: 38445267
Background: Adult Polyglucosan Body Disease (APBD) is an ultra-rare, genetic neurodegenerative disorder caused by autosomal recessive mutations in the glycogen branching enzyme gene. Knowledge of the demographic and clinical characteristics...
4.
Thompson J, Karaa A, Pham H, Yeske P, Krischer J, Xiao Y, et al.
Orphanet J Rare Dis
. 2023 Jul;
18(1):194.
PMID: 37474973
No abstract available.
5.
Thompson J, Karaa A, Pham H, Yeske P, Krischer J, Xiao Y, et al.
Orphanet J Rare Dis
. 2023 Jun;
18(1):157.
PMID: 37349818
Background: Mitochondrial diseases often require multiple years and clinicians to diagnose. We lack knowledge of the stages of this diagnostic odyssey, and factors that affect it. Our goals are to...
6.
Stefancic A, Rogers R, Styke S, Xu X, Buchsbaum R, Nossel I, et al.
JMIR Ment Health
. 2022 Nov;
9(11):e41482.
PMID: 36331539
Background: Mobile health (mHealth) technologies have been used extensively in psychosis research. In contrast, their integration into real-world clinical care has been limited despite the broad availability of smartphone-based apps...
7.
Emmanuele V, Ganesh J, Vladutiu G, Haas R, Kerr D, Saneto R, et al.
Mol Genet Metab
. 2022 May;
136(2):125-131.
PMID: 35606253
Objective: To harmonize terminology in mitochondrial medicine, we propose revised clinical criteria for primary mitochondrial syndromes. Methods: The North American Mitochondrial Disease Consortium (NAMDC) established a Diagnostic Criteria Committee comprised...
8.
Ito K, Li S, Homma S, Thompson J, Buchsbaum R, Matsumoto K, et al.
ESC Heart Fail
. 2021 Sep;
8(6):4997-5009.
PMID: 34545701
Aims: There is limited information on the association between left ventricular (LV) dimensions and cardiovascular (CV) outcomes in patients with heart failure (HF) with reduced LV ejection fraction (HFrEF) receiving...
9.
Shea S, Thompson J, Schwartz J, Chen Y, de Ferrante M, Vanderbeek A, et al.
Am J Hypertens
. 2021 Aug;
35(1):103-110.
PMID: 34382648
Background: Blood pressure (BP) control was only 43.7% in the National Health and Nutrition Survey (NHANES) survey in 2017-2018. Scalable, nonclinic-based strategies to control BP are needed. We therefore conducted...
10.
Matsumoto K, Xiao Y, Homma S, Thompson J, Buchsbaum R, Ito K, et al.
ESC Heart Fail
. 2020 Dec;
8(2):819-828.
PMID: 33377631
Aims: This study aimed to investigate the impact of baseline 6 min walk test distance (6MWTD) on time to major cardiovascular (CV) events in heart failure with reduced ejection fraction...